马运峰

教授

访问量：

最后更新时间：--

校内登录

马运峰

教授

访问量：

最后更新时间：--

发表文章

中文主页

 

  1. Li, D., Ma, Y. B10 cells: Development, phenotype, and function in cancer. Adv Clin Exp Med. 2024, https://doi.org/10.17219/acem/176378. （通讯作者）
  2. Li, D., Ma, Y., Miao, Y., Liu, S., Bi, Y., Ji, Y., Wu, Q., Zhou, C., Ma, Y. Peritoneal B1 and B2 cells respond differently to LPS and IL-21 stimulation. Mol. Immunol. 2024,170, 46-56. （通讯作者）
  3. Lv, Z., Wang, T.Y., Bi, Y., Li, D., Wu, Q., Wang, B., Ma, Y. BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T cell responses. Breast Cancer Res. Treat. 2024,https://doi.org/10.1007/s10549-024-07504-6. （通讯作者）
  4. Wang, X., Miao, Y., Shen, J., Li, D., Deng, X., Yang, C., Ji, Y., Dai, Z., Ma, Y. Unlocking PD-1 antibody resistance: The MUC1 DNA vaccine augments CD8+ T cell infiltration and attenuates tumour suppression. Scand. J. Immunol, 2024, 99, e13356. （通讯作者）
  5. Wang, X., Wang, X., Wang, D., Zhou, C., Lv, K., Ma, Y., Chang, W., Wang, B., Hu, J., Ji, Y., Dai, Z., Ma, Y. Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth. Int. Immunopharmacol. 2024,142, 113089.（通讯作者）
  6. Wang, Y., Miao, Y., Zhou, W., Bi, Y., Ji, Y., Ma, Y., 2023. Activation-induced cytidine deaminase displays an alternative co-factor for modulating PIM1 expression in diffuse large B cell lymphoma cell lines. Cellular and molecular biology (Noisy-le-Grand, France), 2023. 69, 1-7.（通讯作者）
  7. 霍雪萍, 曹情雯, 王海芳, 赵向绒, 王晶, 董静, 马运峰, 2022. 活血胶囊抑制H_2O_2诱导的小鼠主动脉平滑肌细胞衰老的研究. 现代中西医结合杂志 31, 2022,2818-2823. （通讯作者）
  8. 贺龙梅, 王晓倩, 屈洁, 张宁, 王晓琴, 马运峰. 胰腺癌细胞中CHI3L1低表达对肿瘤生长的抑制作用及其机制. 山西医科大学学报. 2022;53:543-7. （通讯作者）
  9. Leavenworth JW, Liu X, Ma Y, Zhu Y, Qi C. Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies. Front Immunol. 2022;13:1023967. （通讯作者）
  10. Ma Y, Zhang Y, Bi Y, He L, Li D, Wang D, et al. Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer. Medicine (Baltimore). 2022;101:e30787. （第一作者）
  11. 邹永妮, 杨健, 马运峰. 血清细胞角蛋白19片段抗原21-1、神经元特异性烯醇化酶在结肠癌中的表达情况及与预后的关系. 癌症进展. 2021;19:2189-91,2228. （通讯作者）
  12. 王晓倩, 李丹丹, 王丹，马运峰. 乳腺癌4T1细胞中过表达鼠白介素-10对宿主抗肿瘤免疫应答的影响. 山西医科大学学报. 2021;52:559-64. （通讯作者）
  13. 张星星, 杨磊, 刘芳, 张瑾, 常丽花, 马运峰. lncRNA CASC9通过靶向miR-195-5p/CDK6轴调控肺鳞癌的进展. 山西医科大学学报. 2021;52:1507-16. （通讯作者）
  14. Yuan M, Wang Y, Qin M, Zhao X, Chen X, Li D, Miao Y, Otieno Odhiambo W, Liu H, Ma Y, Ji Y . RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo. Cancer science. 2021,112(7) 2679-2691.（通讯作者）.
  15. Lv Z, Zhang P, Li D, Qin M, Nie L, Wang X, Ai L, Feng Z, Odhiambo WO, Ma Y, & Ji, Y.: CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models. Oncoimmunology 9: 1747688, 2020. （通讯作者）
  16. Lv, Z., Liu, M., Shen, J., Xiang, D., Ma, Y*, & Ji, Y. Association of serum interleukin‑10, interleukin‑17A and transforming growth factor‑α levels with human benign and malignant breast diseases. Experimental and therapeutic medicine, 2018,15(6), 5475-5480.（通讯作者）
  17. Ma YF#, Chen C#, Li D#, Liu M; Lv ZW; Ji Y; Xu J*. Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer. Oncotarget. 2017 8(5):7614-7624. （第一作者）
  18. Ma YF，Ren Y, Dai ZJ, Wu CJ, Ji YH, Xu JR*.IL-6, IL-8, and TNF- levels correlate with disease stage in breast cancer patients. Adv Clin Exp Med 2017 26(3):421–426（第一作者）
  19. Ma YF#, Ren Y#, Wu CJ#, Zhao XH, Xu H, Wu DZ, Xu J, Zhang XL, Ji Y*. Interleukin (IL)-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancer. Mol Immunol 2016, 75, 11-20. （第一作者）
  20. Dai ZJ#*, Liu XH#, Ma YF#, et al. Association between Single Nucleotide Polymorphisms in DNA polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study. Medicine (Baltimore). 2016. 95(2): e2466. (共同第一作者)
  21. Wang M#, Wang XJ#, Ma YF#, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ*:.PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk. Ther Clin Risk Manag 2015, 11, 237-45. (共同第一作者)
  22. Dai ZJ#*, Wang BF#, Ma YF#, Kang HF, Diao Y, Zhao Y, Lin S, Lv Y, Wang M, Wang XJ: Current evidence on the relationship between rs1256049 polymorphism in estrogen receptor-beta gene and cancer risk. Int J Clin Exp Med 2014, 7, 5031-40.(共同第一作者)
  23. Ding C#, Ma Y#, Chen X, Liu M, Cai Y, Hu X, Xiang D, Nath S, Zhang HG, Ye H, Powell D, Yan J* Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance. Nat Commun 2013, 4, 2813. (共同第一作者)
  24. Ma Y#, Xiang D#, Sun J, Ding C, Liu M, Hu X, Li G, Kloecker G, Zhang HG, Yan J*. Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development. J Immunol 2013, 190, 5588-99. （第一作者）
  25. Ma Y#, Chen HD#, Wang Y#, Wang Q, Li Y, Zhao Y, Zhang XL*:Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection. Microbes Infect 2011, 13, 1099-110. （第一作者）
  26. Ma Y, Chen H, Wang Q, Luo F, Yan J, Zhang XL*.IL-24 protects against Salmonella typhimurium infection by stimulating early neutrophil Th1 cytokine production, which in turn activates CD8+ T cells. Eur J Immunol 2009, 39, 3357-68. （第一作者）
  27. Wang QL#, Pan Q#, Ma Y#, Wang K, Sun P, Liu S, Zhang XL*: An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine 2009, 27, 6712-22. (共同第一作者)
  28. Wang, Y., Zhang, X., Ma, Y., Zhou, X., Xu, W., Qin, S., Yang, C. Self-assembled copper-based nanoparticles for enzyme catalysis-enhanced chemodynamic /photodynamic/antiangiogenic tritherapy against hepatocellular carcinoma. J Nanobiotechnology,2024 22, 375（共同作者）
  29. Jiao J, Lv Z, Zhang P, Wang Y, Yuan M, Yu X, Otieno Odhiambo W, Zheng M, Zhang H, Ma Y, Ji Y (2020). AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines. Neoplasia: an international journal for oncology research 22: 142-153.（共同作者）
  30. Yu X, Zhang H, Yuan M, Zhang P, Wang Y, Zheng M, Lv Z, Odhiambo WO, Li C, Liu C, Ma Y, Ji Y. Identification and characterization of a murine model of  BCR‑ABL1+ acute B‑lymphoblastic leukemia with central nervous system metastasis. Oncology reports, 2019, 42: 521-532.（共同作者）
  31. Liu, M., Zhao, X., Ma, Y., Zhou, Y., Deng, M., & Ma, Y. Transcription factor c‐Maf is essential for IL‐10 gene expression in B cells. Scandinavian journal of immunology, 2018,88(3), e12701.(共同作者)
  32. Ma YF, He LM, Wu Q, Ma YF, Wang XQ (2018). [Detection of chitinase 3-like 1 combined with other biomarkers for diagnosis of pancreatic cancer]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 38: 450-454.
  33. Zhao W, Dong Y, Wu C, Ma Y, Jin Y, Ji Y. TIGIT overexpression diminishes the function of CD4 T cells and ameliorates the severity of rheumatoid arthritis in mouse models. Exp Cell Res. 2016. 340(1): 132-8.
  34. Liu M, Luo F, Ding C, Albeituni S, Hu X, Ma Y, Cai Y, McNally L, Sanders MA, Jain D, Kloecker G, Bousamra M, Zhang HG, Higashi RM, Lane AN, Fan TW, Yan J. Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype. J Immunol 2015; 195:5055-65;
  35. Zhao W, Dong Y, Wu C, Ma Y, Jin Y, Ji Y: MiR-21 overexpression improves osteoporosis by targeting RECK. Mol Cell Biochem 2015, 405, 125-33.
  36. Zhao W, Wu C, Dong Y, Ma Y, Jin Y, Ji Y: MicroRNA-24 Regulates Osteogenic Differentiation via Targeting T-Cell Factor-1. Int J Mol Sci 2015, 16, 11699-712.
  37. Cai Y, Xue F, Fleming C, Yang J, Ding C, Ma Y, Liu M, Zhang HG, Zheng J, Xiong N, Yan J: Differential developmental requirement and peripheral regulation for dermal Vgamma4 and Vgamma6T17 cells in health and inflammation. Nat Commun 2014, 5, 3986.
  38. Gunn L, Ding C, Liu M, Ma Y, Qi C, Cai Y, Hu X, Aggarwal D, Zhang HG, Yan J: Opposing roles for complement component C5a in tumor progression and the tumor microenvironment. J Immunol 2012, 189, 2985-94.

 

版权所有：西安交通大学 陕ICP备05001571号